AI assistant
PFIZER INC — Director's Dealing 2019
Mar 2, 2019
29831_dirs_2019-03-01_25a6d7f7-c5a7-4004-a602-38afa2bc6175.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-27
Reporting Person: BOURLA ALBERT (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-27 | Common Stock | A | 96183.0000 | $0.0000 | Acquired | 267660.0000 | Direct |
| 2019-02-27 | Common Stock | M | 64322.0000 | $32.2300 | Acquired | 331982.0000 | Direct |
| 2019-02-27 | Common Stock | F | 12046.0000 | $42.9300 | Disposed | 319936.0000 | Direct |
| 2019-02-27 | Common Stock | F | 39724.0000 | $42.3100 | Disposed | 280212.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-27 | Stock Appreciation Rights | $32.2300 | M | 64322.0000 | Disposed | 2019-02-27 | Common Stock (64322.0000) | Direct |
| 2019-02-28 | Stock Appreciation Rights | $43.3500 | A | 361005.0000 | Acquired | 2024-02-28 | Common Stock (361005.0000) | Direct |
| 2019-02-28 | Stock Appreciation Rights | $43.3500 | A | 304228.0000 | Acquired | 2026-02-28 | Common Stock (304228.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3133.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F2: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.